Literature DB >> 29379995

Evidence for encephalopsin immunoreactivity in interneurones and striosomes of the monkey striatum.

Nabil El Massri1, Karen M Cullen1, Sebastian Stefani1, Cécile Moro2, Napoleon Torres2, Alim-Louis Benabid2, John Mitrofanis3.   

Abstract

In this study, we examined the cellular distribution of encephalopsin (opsin 3; OPN3) expression in the striatum of non-human primates. In addition, because of our long standing interest in Parkinson's disease and neuroprotection, we examined whether parkinsonian (MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) insult and/or photobiomodulation (670 nm) had any impact on encephalopsin expression in this key area of the basal ganglia. Striatal sections of control naïve monkeys, together with those that were either MPTP- and/or photobiomodulation-treated were processed for immunohistochemistry. Our results revealed two populations of striatal interneurones that expressed encephalopsin, one of which was the giant, choline acetyltransferase-containing, cholinergic interneurones. The other population had smaller somata and was not cholinergic. Neither cell group expressed the calcium-binding protein, parvalbumin. There was also rich encephalopsin expression in a set of terminals forming striosome-like patches across the striatum. Finally, we found that neither parkinsonian (MPTP) insult nor photobiomodulation had any effect on encephalopsin expression in the striatum. In summary, our results revealed an extensive network of encephalopsin containing structures throughout the striatum, indicating that external light is in a position to influence a range of striatal activities at both the interneurone and striosome level.

Entities:  

Keywords:  Acetylcholine; Caudate; MPTP; OPN3; Photobiomodulation; Putamen

Mesh:

Substances:

Year:  2018        PMID: 29379995     DOI: 10.1007/s00221-018-5191-9

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  17 in total

Review 1.  Functional changes of the basal ganglia circuitry in Parkinson's disease.

Authors:  F Blandini; G Nappi; C Tassorelli; E Martignoni
Journal:  Prog Neurobiol       Date:  2000-09       Impact factor: 11.685

Review 2.  Therapies in Parkinson's disease.

Authors:  Joseph Jankovic; Werner Poewe
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

Review 3.  Striatal interneurones: chemical, physiological and morphological characterization.

Authors:  Y Kawaguchi; C J Wilson; S J Augood; P C Emson
Journal:  Trends Neurosci       Date:  1995-12       Impact factor: 13.837

4.  Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment.

Authors:  Victoria E Shaw; Sharon Spana; Keyoumars Ashkan; Alim-Louis Benabid; Jonathan Stone; Gary E Baker; John Mitrofanis
Journal:  J Comp Neurol       Date:  2010-01-01       Impact factor: 3.215

5.  Encephalopsin: a novel mammalian extraretinal opsin discretely localized in the brain.

Authors:  S Blackshaw; S H Snyder
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

6.  Transcranial light affects plasma monoamine levels and expression of brain encephalopsin in the mouse.

Authors:  Antti Flyktman; Satu Mänttäri; Juuso Nissilä; Markku Timonen; Seppo Saarela
Journal:  J Exp Biol       Date:  2015-03-24       Impact factor: 3.312

Review 7.  Shining light on the head: Photobiomodulation for brain disorders.

Authors:  Michael R Hamblin
Journal:  BBA Clin       Date:  2016-10-01

8.  Why and how does light therapy offer neuroprotection in Parkinson's disease?

Authors:  John Mitrofanis
Journal:  Neural Regen Res       Date:  2017-04       Impact factor: 5.135

9.  Near-infrared light is neuroprotective in a monkey model of Parkinson disease.

Authors:  Fannie Darlot; Cécile Moro; Nabil El Massri; Claude Chabrol; Daniel M Johnstone; Florian Reinhart; Diane Agay; Napoleon Torres; Dhaïf Bekha; Vincent Auboiroux; Thomas Costecalde; Cassandra L Peoples; Helena D T Anastascio; Victoria E Shaw; Jonathan Stone; John Mitrofanis; Alim-Louis Benabid
Journal:  Ann Neurol       Date:  2015-12-12       Impact factor: 11.274

Review 10.  Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease.

Authors:  Daniel M Johnstone; Cécile Moro; Jonathan Stone; Alim-Louis Benabid; John Mitrofanis
Journal:  Front Neurosci       Date:  2016-01-11       Impact factor: 4.677

View more
  6 in total

Review 1.  Current application and future directions of photobiomodulation in central nervous diseases.

Authors:  Muyue Yang; Zhen Yang; Pu Wang; Zhihui Sun
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

2.  Photobiomodulation reduces gliosis in the basal ganglia of aged mice.

Authors:  Nabil El Massri; Tobias W Weinrich; Jaimie Hoh Kam; Glen Jeffery; John Mitrofanis
Journal:  Neurobiol Aging       Date:  2018-02-26       Impact factor: 4.673

3.  Photobiomodulation for Parkinson's Disease in Animal Models: A Systematic Review.

Authors:  Farzad Salehpour; Michael R Hamblin
Journal:  Biomolecules       Date:  2020-04-15

Review 4.  The effect of photobiomodulation on the brain during wakefulness and sleep.

Authors:  Cecile Moro; Audrey Valverde; Marjorie Dole; Jaimie Hoh Kam; Catherine Hamilton; Ann Liebert; Brian Bicknell; Alim-Louis Benabid; Pierre Magistretti; John Mitrofanis
Journal:  Front Neurosci       Date:  2022-07-28       Impact factor: 5.152

5.  Endogenous Opsin 3 (OPN3) Protein Expression in the Adult Brain Using a Novel OPN3-mCherry Knock-In Mouse Model.

Authors:  Lauren E Olinski; Ayumi C Tsuda; Julie A Kauer; Elena Oancea
Journal:  eNeuro       Date:  2020-09-03

6.  Airway smooth muscle photorelaxation via opsin receptor activation.

Authors:  Peter D Yim; George Gallos; Jose F Perez-Zoghbi; Yi Zhang; Dingbang Xu; Amy Wu; Dan E Berkowitz; Charles W Emala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-04       Impact factor: 5.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.